Added to YB: 2020-09-16
Pitch date: 2020-09-16
VXRT:US [bearish]
Vaxart, Inc.
+95.14%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform.
Market Cap
$169.7M
Pitch Price
$7.61
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.45
P/E
-1.86
EV/Sales
8.00
Sector
Biotechnology
Category
N/A
Show full summary:
VAXART INC COM VXRT:US
A summary for this pitch has not been created yet.
Read full article (0 min)